Skip to content
healthcare.dev

Bortezomib

NDC 51817-586, bortezomib, injection, powder, lyophilized, for solution, from Pharmascience Inc..

Product NDC
51817-586
Status
Listed
Labeler
Pharmascience Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208392
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51817-586 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BORTEZOMIB3.5 mg/1

Pharmacologic classes

Proteasome Inhibitor [EPC]; Proteasome Inhibitors [MoA]

Package NDCNDC-11Package
51817-586-01518170586011 VIAL in 1 CARTON (51817-586-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/191d231a-1fbd-4a65-9d33-d5dc03bac381

Use it

Look up 51817-586 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51817-586 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51817-586. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.